Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

Spongy Bone

Spongy Bone

All bones comprise an outer layer of compact bone, and an interior made up of spongy bone tissue, also called cancellous or trabecular bone. In long bones, spongy bone tissue is mainly found in the interior of the epiphyses (broad ends of the bone).
Spongy bone is more porous, and less dense compared to compact bone. It is composed of concentric lamellae that are arranged irregularly to form the trabecular network. In some bones, the spaces between trabeculae contain red marrow, where...

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Variability in epilepsy polygenic risk prediction across Taiwanese population and clinical cohorts.

Epilepsia·2026

Same author

The Role of Molecular Testing in Head and Neck Squamous Cell Carcinoma of Unknown Primary.

Head and neck pathology·2026

Same author

Optimizing Systemic Therapy for Advanced Sarcomas: Outcomes With Gemcitabine, Docetaxel, Cisplatin, and Everolimus in a Retrospective Single-Center Study.

Cancer medicine·2026

Same author

Malignant Transformation of Sinonasal Papilloma: Assessment of Clinicopathologic Features, p16 and p53 Expression, Transcriptionally Active HPV Status and Underlying Molecular Alterations.

Head and neck pathology·2026

Same author

Renal tumors harboring FLCN mutations: Case series from clinical practice.

Human pathology·2026

Same author

Out-of-frame CBX3::ALK fusion drives ALK activation and therapy response.

Cell reports. Medicine·2026

Search research articles

Related Experiment Video

Updated: Apr 30, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Parosteal osteosarcoma.

Jen-Fan Hang¹, Paul Chih-Hsueh Chen

¹From the Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

Archives of Pathology & Laboratory Medicine

|May 3, 2014

Summary

This summary is machine-generated.

Parosteal osteosarcoma, a rare bone tumor, presents as a slow-growing mass and is often misdiagnosed. Genetic analysis, including CDK4 and MDM2 gene amplification, aids in its diagnosis and understanding.

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Related Experiment Videos

Last Updated: Apr 30, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Area of Science:

Oncology
Pathology
Genetics

Background:

Parosteal osteosarcoma is a rare malignant bone tumor originating from the bone's cortical surface.
It typically affects young women, often appearing near the knee joint as a slow-growing mass.
Its bland microscopic features can lead to misdiagnosis as benign tumors.

Purpose of the Study:

To review the clinical, radiologic, and pathologic features of parosteal osteosarcoma.
To identify diagnostic pitfalls associated with this rare bone tumor.
To update on molecular advances and their diagnostic applications.

Main Methods:

Review of clinical presentations and patient histories.
Analysis of radiologic imaging characteristics.
Pathologic examination of tumor morphology.
Examination of cytogenetic data, focusing on gene amplifications.

Main Results:

Parosteal osteosarcoma exhibits slow growth and can be mistaken for benign conditions.
Distinctive cytogenetic abnormalities, such as CDK4 and MDM2 gene amplification, are noted.
Prognosis is generally favorable if dedifferentiation is absent.

Conclusions:

Accurate diagnosis requires integrating clinical, radiologic, and pathologic findings.
Molecular markers like CDK4 and MDM2 amplification are valuable for diagnosis.
Understanding these features improves patient outcomes for parosteal osteosarcoma.